Comprehensive Overview of Gastrointestinal Internal Medicine
History Taking in GI Medicine
The foundation of GI evaluation begins with empathic, active listening—dedicating at least 2 minutes at the consultation start significantly improves patient confidence, treatment adherence, and reduces healthcare visits 1.
Essential Historical Elements
Symptom Onset and Temporal Relationships:
- Document precise symptom onset timing—this is the critical first question 1
- For abdominal pain, establish the relationship between pain and bowel habit changes (pain relieved/exacerbated by defecation, or temporally associated with stool frequency/consistency changes) 1
- Pain location can be upper or lower abdomen—both are relevant 1
Trigger Identification:
- Post-infectious onset (present in ~10% of IBS cases) 1
- Recent antibiotic exposure 1
- Acute or chronic psychological stress/trauma 1
- Medication history, particularly opioids 1
Symptom Characterization:
- Use Bristol Stool Chart to classify predominant stool pattern on abnormal days 1
- Document bloating and visible abdominal distension (highly suggestive of IBS when present) 1
- Elicit extraintestinal symptoms: back pain, urological, gynecological complaints 1
- Screen for other functional non-GI disorders 1
Red Flags to Exclude:
- Alarm symptoms requiring immediate investigation
- Unintentional weight loss
- Rectal bleeding (beyond hemorrhoidal)
- Progressive dysphagia
- Persistent vomiting
- Family history of GI malignancy
Physical Examination Approach
While the provided guidelines focus heavily on history, physical examination should systematically assess:
- Abdominal inspection for distension, surgical scars, visible peristalsis
- Palpation for organomegaly, masses, tenderness patterns
- Percussion for ascites, organomegaly
- Auscultation for bowel sounds quality
- Digital rectal examination when indicated
- Assessment for extraintestinal manifestations (skin, joints, eyes)
Diagnostic Workup Algorithm
Primary Care/Initial Secondary Care Baseline Investigations
Mandatory first-line tests 1:
- Full blood count
- C-reactive protein OR erythrocyte sedimentation rate
- Coeliac serology
- Faecal calprotectin (if diarrhea AND age <45 years) 1
Decision Point: Need for Further Investigation
Make a positive diagnosis WITHOUT additional testing when 1:
- Cardinal symptoms present (abdominal pain with altered bowel habit relationship)
- No alarm features
- Normal baseline investigations
- Age-appropriate cancer screening completed
Proceed to endoscopy when 1, 2:
- Diagnostic uncertainty persists
- Symptoms severe or refractory to first-line treatments
- Patient requests specialist opinion
- Abnormal baseline investigations
- Age >45 years with new-onset symptoms (lower threshold for investigation)
Endoscopic Evaluation
Upper endoscopy with gastric biopsies 2:
- Documents H. pylori status definitively
- Identifies structural disease (ulcers, malignancy, eosinophilic esophagitis)
- Provides positive diagnosis of functional dyspepsia when normal
- Initial diagnostic modality for hemodynamically stable acute lower GI bleeding
- Both diagnostic and therapeutic capabilities
- Should be performed in stable patients with appropriate bowel preparation
Advanced Diagnostic Modalities
When endoscopy is non-diagnostic or bleeding source unclear 3, 4:
- CT angiography (CTA): critical for hemodynamically unstable patients or when colonoscopy fails
- 24-hour esophageal pH monitoring for atypical GERD 2
- Small bowel imaging for obscure bleeding
Management of Common GI Disorders
Irritable Bowel Syndrome (IBS)
Treatment selection based on predominant symptom pattern 1, 5:
For ulcer-like/pain-predominant symptoms:
- Full-dose PPI therapy as first-line 2
- Antispasmodics for cramping pain 5
- Neuromodulators (tricyclic antidepressants at low doses) 5
For dysmotility-like symptoms (fullness, bloating, early satiety):
- Prokinetic agents (note: cisapride contraindicated due to cardiac toxicity) 2
- Dietary modifications addressing fermentable carbohydrates
For refractory cases 5:
- Antidepressants (tricyclics or SSRIs) for central pain processing
- Psychotherapy in motivated individuals (equally effective as pharmacotherapy) 5
- Address psychological comorbidity directly
Treatment duration strategy 2:
- Initial course of empirical therapy
- Trial withdrawal if symptoms controlled
- Restart therapy on-demand for recurrence
- Switch medication classes if first choice fails (e.g., prokinetic to PPI or vice versa)
Functional Dyspepsia
Symptom-directed approach 2:
Ulcer-like dyspepsia:
- Full-dose PPI therapy first-line
- Confirms acid-related nature if responsive
- Ensures healing of H. pylori-negative ulcers
Dysmotility-like dyspepsia:
- Prokinetic agent as first option
- Switch to high-dose PPI if non-responsive (may represent misclassified GERD)
Resistant functional dyspepsia 2:
- Re-evaluate diagnosis
- Consider behavioral therapy, psychotherapy, or antidepressants
- Visceral analgesic therapies in specialist setting
Acute GI Bleeding
Initial management priorities 3, 4:
Hemodynamically unstable patients:
- Immediate resuscitation with IV crystalloids targeting heart rate/blood pressure normalization BEFORE diagnostic procedures 3
- CTA as diagnostic modality of choice 3
- Multidisciplinary approach involving gastroenterology, interventional radiology, surgery
Hemodynamically stable patients:
- Colonoscopy as initial diagnostic and therapeutic modality 3, 4
- Endoscopic hemostatic measures: adrenaline injection, clip application, thermal coagulation, band ligation 3
Special populations:
- Patients on anticoagulants/antiplatelets or with recent cardiac stenting (<1 year): mandatory multidisciplinary approach 3
Common Pitfalls and How to Avoid Them
Pitfall 1: Dismissing IBS as "purely psychological"
- IBS has clear pathophysiological mechanisms (altered gut sensitivity, motility, microbiota, immune function) 5
- Psychological factors are modulators, not primary causes
- Validate the diagnosis to build trust 1
Pitfall 2: Over-investigating functional disorders
- Make positive diagnoses based on symptom patterns and normal baseline tests 1
- Excessive testing reinforces patient anxiety about missed organic disease
- Set clear expectations: no cure exists, treatments target quality of life improvement 1
Pitfall 3: Single-agent treatment failure = treatment failure
- Switch medication classes before declaring failure 2
- Consider high-dose PPI trial even after initial PPI failure
- Address biopsychosocial factors concurrently 5
Pitfall 4: Inadequate resuscitation before procedures
- Never proceed to colonoscopy in hemodynamically unstable lower GI bleeding 3
- Normalize vital signs first, then investigate
Pitfall 5: Poor doctor-patient relationship
- Treatment success directly correlates with relationship quality 5
- Empathic listening is therapeutic, not just diagnostic 1
- Manage expectations explicitly about chronic nature and treatment goals 1
Quality of Life Considerations
The biopsychosocial model is mandatory for functional GI disorders 5:
- Lifestyle and dietary modifications
- Address psychological comorbidity directly
- Pharmacological treatment targeting pathophysiology
- Psychotherapy for motivated individuals
Treatment success metrics 2:
- Symptom improvement
- Reduced healthcare utilization
- Enhanced quality of life over 3+ months post-treatment
- Improved treatment adherence through empathic care 1